Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Glioblastoma Multiforme

In brief

The purpose of the study is to determine the effectiveness of an investigational drug called lucanthone, when combined with temozolomide (TMZ) and radiation in the treatment of Glioblastoma Multiforme (GBM).

Key facts

Study ID

NCT01587144

Run by

Spectrum Pharmaceuticals, Inc

People needed

18

Starts

2012-06-19

Expected to finish

2013-04-15

Last updated by the study team

2021-10-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UCSD Moores Cancer Center — La Jolla, California, United States
• UCI Medical Center — Orange, California, United States
• Dent Neurologic Institute — Amherst, New York, United States
• Fairview Hospital Moll Cancer Center/Cleveland Clinic — Cleveland, Ohio, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Hillcrest Hospital Hirsh Cancer Center/Cleveland Clinic — Mayfield, Ohio, United States
• Gujarat Cancer Research Institute — Ahmedabad, Gujarat, India
• Jaslok Hospital & Research Centre — Mumbai, Maharashtra, India
• Bhagwan Mahaveer Cancer Hospital & Reseach Centre — Jaipur, Rajasthan, India
• Chittaranjan National Cancer Institute — Kolkata, West Bengal, India

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.